)
Quantum Cyber (QUCY) investor relations material
Quantum Cyber Proxy Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
An extraordinary shareholders' meeting is scheduled to vote on major proposals, including auditor ratification, share issuances, amendments to the Articles of Association, reverse share split, director appointments, incentive plan amendments, remuneration policy changes, and board resolution approvals.
The meeting will address a significant private placement investment, resulting in the potential issuance of over 95% of outstanding shares to a new investor, subject to shareholder approval.
The board recommends voting in favor of all proposals, which are considered critical for the company's future direction and compliance with Nasdaq requirements.
Voting matters and shareholder proposals
Proposals include ratifying Reliant CPA PC as auditor, approving share issuances for preferred shares, amending the Articles for share conversions and a name change, authorizing a reverse share split, appointing four directors, increasing shares under the incentive plan, amending the remuneration policy, and approving board resolutions related to the investment.
Shareholders will vote on increasing authorized share capital, converting preferred shares, and changing the company name to Quantum Cyber N.V.
Approval of these proposals is a condition for the final closing of the $6 million investment and related settlement agreements.
Board of directors and corporate governance
Four director nominees are proposed: David Lazar (to become CEO), Robert Liscouski, David Natan, and Avraham Ben-Tzvi, all with significant public company and industry experience.
If elected, the current board (except Lazar) and executive officers will resign, and the new board will be composed of a majority of independent directors.
New board committees will be formed, with anticipated appointments of independent directors to audit, compensation, and nomination committees.
- Offering up to $150M in securities to advance innovative cancer diagnostics amid high risk.QUCY
Registration Filing16 Dec 2025 - Up to 4.59 million shares and units are offered, with Maxim Group LLC as placement agent.QUCY
Registration Filing30 Nov 2025 - IPO aims to fund CRC diagnostics growth amid financial risk and Nasdaq compliance challenges.QUCY
Registration Filing29 Nov 2025 - Best-efforts offering seeks $5.33M for cancer diagnostics R&D and expansion, with high investor risk.QUCY
Registration Filing29 Nov 2025 - Offering up to $7.1M net to fund CRC diagnostics expansion, with high dilution and Nasdaq risks.QUCY
Registration Filing29 Nov 2025 - Raising up to $6M for cancer diagnostics, with high risk, dilution, and strong market potential.QUCY
Registration Filing29 Nov 2025 - Cancer diagnostics firm launches high-risk, dilutive best-efforts IPO to fund clinical and commercial growth.QUCY
Registration Filing29 Nov 2025 - Offering up to 30.8M shares/warrants to fund CRC diagnostics amid financial and Nasdaq risks.QUCY
Registration Filing29 Nov 2025 - Revenue up, losses down, and strategic focus sharpened for 2025 growth and FDA progress.QUCY
H1 202413 Jun 2025
Next Quantum Cyber earnings date
Next Quantum Cyber earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)